Gain Therapeutics, Inc. (GANX) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-0.61 | +31.5% |
| 2024 | $-0.89 | +48.0% |
| 2023 | $-1.71 | -15.5% |
| 2022 | $-1.48 | -8.0% |
| 2021 | $-1.37 | -3.0% |
| 2020 | $-1.33 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-0.61 | +31.5% |
| 2024 | $-0.89 | +48.0% |
| 2023 | $-1.71 | -15.5% |
| 2022 | $-1.48 | -8.0% |
| 2021 | $-1.37 | -3.0% |
| 2020 | $-1.33 | — |